Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 2 de 2
Filtre
1.
Chinese Journal of Surgery ; (12): 1428-1431, 2007.
Article Dans Chinois | WPRIM | ID: wpr-338140

Résumé

<p><b>OBJECTIVE</b>To observe the curative effects of bone marrow stem cell (BMSC) and peripheral blood stem cell (PBSC) transplantations on the avascular necrosis of femoral head (ANFH).</p><p><b>METHODS</b>Totally 122 ANFH patients (211 coxae) treated by BMSC or PBSC transplantations were enrolled from July 2004 to December 2006. All of them were classed to different stages according to the ARCO. Control group were desired as themselves before and after treatment. The puncture of femoral artery was conducted with digital subtraction angiography (DSA), and the tubes were inserted into medial femoral circumflex artery, lateral femoral circumflex artery and obturator artery with the cell suspensions were gradually poured into the arteries.</p><p><b>RESULTS</b>The joint pain, joint functions and walking distance of 122 patients were detected for the follow-up. Compared with before treatment, the calibers thickened; vessels increased and blood velocity quickened of femoral head blood-supply artery were observed in 15 patients after 6 months checked by DSA. The reduced areas of femoral head necrosis in 8 patients indicated the new bone formation between 12 and 24 months.</p><p><b>CONCLUSIONS</b>Autologous BMSC and PBSC transplantation results in the new bone formation and improvement of ischemia in areas of femoral head necrosis at 6 months. The change of angiography was observed about 12 to 24 months after cell transplantation. The stem cell transplantation is convenient, safe and effective in the treatment of the ANFH with no adverse reaction, and can be considered as a new therapy of ANFH.</p>


Sujets)
Humains , Transplantation de moelle osseuse , Tête du fémur , Anatomopathologie , Chirurgie générale , Nécrose de la tête fémorale , Chirurgie générale , Études de suivi , Ischémie , Chirurgie générale , Transplantation de cellules souches de sang périphérique , Transplantation de cellules souches , Méthodes , Transplantation autologue , Résultat thérapeutique
2.
Journal of Experimental Hematology ; (6): 557-560, 2002.
Article Dans Chinois | WPRIM | ID: wpr-337674

Résumé

The purpose of this study is to explore the clinical significance of RBC blood group serological test in nonmyeloablative allogeneic peripheral blood stem cell transplantation (NAPBSCT) of ABO group incompatibility in 4 patients with acute leukemia. ABO and MN blood group of donors and recipients were determined by hemagglutination test and Rh blood group by Diana Gel phenotype Rh card. The changes of blood group in recipients were observed and implant of donor cells was monitored by short tandem repeat-PCR method. The results showed that in 2 cases of 4 recipients the marrow cells appeared mixed chimera of donor and recipient cells, and blood group changed to donor type in 1 of the 2 cases on 100 days after transplantation. In another 2 cases, the marrow cells appeared mixed chimera without blood group chimera on 154 days after transplantation, and rejection of the transplant occurred in 1 of the 2 cases. The determination of hemagglutinin titer showed that the implant rate of donor cells was lower in the recipients with higher hemagglutinin titer and blood group chimera did not appear, conversely, the implant rate was higher in the recipients with lower titer and blood group chimera appeared early. It is concluded that examination of RBC blood group in NAPB SCT can indirectly reflect effectiveness of transplantation, contribute to decide the intensity of conditioning protocol and immunosuppressive therapy after transplantation, estimate prognosis and guide blood transfusion during transplantation.


Sujets)
Adulte , Femelle , Humains , Adulte d'âge moyen , Antigènes de groupe sanguin , Transfusion sanguine , Leucémie aigüe myéloïde , Sang , Thérapeutique , Transplantation de cellules souches de sang périphérique , Leucémie-lymphome lymphoblastique à précurseurs B et T , Sang , Thérapeutique , Transplantation homologue
SÉLECTION CITATIONS
Détails de la recherche